Source:http://linkedlifedata.com/resource/pubmed/id/16107149
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
17
|
pubmed:dateCreated |
2005-8-18
|
pubmed:abstractText |
The pyrimidine nucleoside beta-d-2'-deoxy-2'-fluoro-2'-C-methylcytidine (1) was designed as a hepatitis C virus RNA-dependent RNA polymerase (HCV RdRp) inhibitor. The title compound was obtained by a DAST fluorination of N(4)-benzoyl-1-(2-methyl-3,5-di-O-benzoyl-beta-d-arabinofuranosyl]cytosine to provide N(4)-benzoyl-1-[2-fluoro-2-methyl-3,5-di-O-benzoyl-beta-d-ribofuranosyl]cytosine. The protected 2'-C-methylcytidine was obtained as a byproduct from the DAST fluorination and allowed for the preparation of two biologically active compounds from a common precursor. Compound 1 and 2'-C-methylcytidine were assayed in a subgenomic HCV replicon assay system and found to be potent and selective inhibitors of HCV replication. Compound 1 shows increased inhibitory activity in the HCV replicon assay compared to 2'-C-methylcytidine and low cellular toxicity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-2623
|
pubmed:author |
pubmed-author:ClarkJeremy LJL,
pubmed-author:FurmanPhillip APA,
pubmed-author:HolleckerLaurentL,
pubmed-author:LostiaStefaniaS,
pubmed-author:MasonJ ChristianJC,
pubmed-author:McBrayerTamara RTR,
pubmed-author:OttoMichael JMJ,
pubmed-author:PankiewiczKrzysztof WKW,
pubmed-author:PattersonSteven ESE,
pubmed-author:SchinaziRaymond FRF,
pubmed-author:StecWojciech JWJ,
pubmed-author:StuyverLieven JLJ,
pubmed-author:TharnishPhillip MPM,
pubmed-author:WatanabeKyoichi AKA
|
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5504-8
|
pubmed:meshHeading |
pubmed-meshheading:16107149-Antiviral Agents,
pubmed-meshheading:16107149-Crystallography, X-Ray,
pubmed-meshheading:16107149-Deoxycytidine,
pubmed-meshheading:16107149-Drug Design,
pubmed-meshheading:16107149-Hepacivirus,
pubmed-meshheading:16107149-Molecular Structure,
pubmed-meshheading:16107149-Structure-Activity Relationship,
pubmed-meshheading:16107149-Virus Replication
|
pubmed:year |
2005
|
pubmed:articleTitle |
Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication.
|
pubmed:affiliation |
Pharmasset, Inc., 303-A College Road East, Princeton, New Jersey 08540, USA.
|
pubmed:publicationType |
Journal Article
|